Washington, D.C. 20549
FORM 12b-25
Notification of Late Filing
---------------
SEC FILE NUMBER
87-0446395
---------------
---------------
CUSIP NUMBER
641 24R 107
---------------
(Check One)
{ X } Form 10-KSB { } Form 11-K { } Form 20-F { } Form 10-Q
{ } Form N-SAR
For Period Ended: December 31, 1996
Nothing in this Form shall be construed to imply that the Commission has
verified any information herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification
relates:_______________________________________________
PART I - Registrant Information
Full name of Registrant NEUROCORP, LTD.
(Former Name, if Applicable)
Address of Principal Executive Office 150 WHITE PLAINS ROAD
(Street and Number)
City, State and Zip Code TARRYTOWN, NEW YORK 10591
PART II - Rules 12b-25 (b) and (c)
If the subject report could not be filed without reasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12(b-25(b), the following
should be completed. (Check box if appropriate)
{ X } (a) The reasons described in reasonable detail in Part II of this form
could not be eliminated without unreasonable effort or expense;
{ X } (b) The subject annual report on Form 10-KSB will be filed on or before
the fifteenth calendar day following the prescribed due date.
{ } (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
<PAGE>
PART III - Narrative
State below in reasonable detail the reason why the Form 10-KSB could not be
filed within the prescribed time period.
Registrant is still awaiting third party confirmations.
The inability to file timely could not be eliminated by the Registrant
without unreasonable effort and expense in that until such confirmations
are received, it cannot finalize its financial statements.
PART IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
AILEEN A. KUNITZ (914) 631 - 3316
---------------- ------------------
(Name) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
{ X } Yes { } No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statement to be included in the subject report or portion
thereof? If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
{ X } Yes { } No
Registrant anticipates reporting a net loss for the year ended
December 31, 1996 of approximately ($ 1,634,675) as compared to a
net loss of ($ 262,494) for the year ended December 31, 1995.
<PAGE>
NEUROCORP, LTD.
--------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Dated: March 31, 1997 By: S/ AILEEN A. KUNITZ
-------------------
Aileen A. Kunitz
CFO